Quinn Everts

Sometimes, breaches in information are the result of a simple mistake. How can those be avoided?

The act is currently set to go into effect in just over three months.

The world continues to become more automated, but how much responsibility should you give AI within your pharmacy?

What are pharmacies capable of, and how do we work to reach those possibilities?

A study presented at Digestive Disease Week 2023 compared the effectiveness of different approaches to prevent complications in individuals with the common disease.

Hesitation from patients and providers to switch to an infliximab biosimilar may not be necessary, new study finds.

What does the future of digital health look like?

What is the state of OTC contraception, what’s next for IUDs, and why are so many transgender people denied care?

A recent study examined the effects that different work environments can have on adults with asthma.

A look at how the genetics-based research field can become more fully integrated in all areas of health care going forward.

The role of pharmacy benefit managers in the health care space is being scrutinized more than ever before.

A research article outlines the future of artificial intelligence in health care.

Researchers found an increased occurrence of CDI in individuals who were prescribed antidepressants.

New data from Digestive Disease Week furthers evidence that biologics can be effective

Data presented at Digestive Disease Week show that patients with IBD had less intense post-vaccination symptoms after a fourth dose.

Keeping inventory in pharmacy is already difficult. And keeping stock of dangerous substances like opioids requires even more caution.

How much does education about the specific risks of smoking assist in smoking cessation?

Over 400 pharmaceutical employees and executives signed an open letter in a show of solidarity with the FDA, but some say that big pharma’s actions helped lead to this moment in the first place.

A new study from JAPHA explores the link between OUD and social factors.

The FDA, state governors, and OB/GYN groups around the country are fighting back against Judge Matthew Kacsmaryk’s ruling.

The biopharmaceutical company says it is “extremely disappointed” with the results of the COURAGE-ALS study, which failed to meet primary or secondary endpoints.

The drug is a rare FDA-approved liquid formulation that treats ulcers and lowers risk of gastrointestinal bleeding in chronically ill patients.

According to a recent study, the diabetes medication semaglutide is more effective as a 25 mg or 50 mg dose on its own, rather than a 14 mg add-on dose with other medications.

Two posters presented at APhA in Phoenix examined the efficacy of the Omnipod® 5 Automated Insulin Delivery System.

COVID-19 misinformation is common. A study presented at the annual APhA meeting examined how new pharmacy practitioners responded to misinformation and tried to minimize its spread.

The drug, branded as Rezzayo, is the first FDA-approved invasive candidiasis treatment in over a decade.

About 1 in 10 individuals in the United States have diabetes. A recent study examines how much they are paying on average for access to treatment for the common disease.

New research examines how individuals with continuing COVID-19 symptoms are managing the virus.

Rural communities are often left without adequate assistance in times of need, but pharmacists can provide crucial care.